HK Stock Market Move | YIDU TECH (02158) rose more than 15% in early trading. YIDU TECH affiliate company won the bid for Tianjin's "Big Data Platform Project".

YIDU TECH (02158) continued to rise by over 15% in early trading, following a close of nearly 33% yesterday. As of the time of writing, it is up 14.91% at HK$6.31, with a turnover of HK$131 million. On the news front, on November 12, YIDU TECH issued a self-disclosure announcement, disclosing a recent major bid-winning information. The announcement revealed that YIDU TECH's affiliated company Yidu Cloud (Beijing) Technology Co., Ltd. won the Tianjin Binhai New Area Economic-Technological Development Area Health Medical Big Data Platform project, with a total amount of approximately RMB 21.76 million. It is understood that this project covers various aspects including resident health record management, chronic disease management platform, digital therapy, and large-scale intelligent consultation services, demonstrating significant innovation. This platform not only integrates and manages comprehensive resident health records but also provides continuous disease monitoring and intervention measures through the chronic disease management platform, as well as digital therapy services and large-scale intelligent consultation, offering a more intelligent non-pharmacological treatment option for patients. This series of service innovations will not only help improve the service quality and efficiency of the medical and health industry in Tianjin City, reduce medical costs, enhance patient satisfaction, but also promote the development of the local medical and health industry. In addition, through the application of advanced technologies such as digital therapy and large-scale models, it will drive technological progress and industry upgrading in the medical and health field in Tianjin City and even nationwide. It is worth noting that the company will hold a board meeting on November 21 (next Thursday). CICC previously pointed out that the company focuses on core business, focuses on improving operating efficiency and profit quality, and continues to invest in AI. EB SECURITIES previously pointed out that as AI empowers product unit price increases and further leverages operational effects, it is expected to turn losses into profits in FY27, bullish on the company's self-developed medical vertical field large language model YiduCore, while considering the vast growth space of the HMPS sector.